Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis

NCT06154447 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-828
DRUG: Placebo
DRUG: Itraconazole
DRUG: Midazolam
DRUG: Tezacaftor
DRUG: VX-118
DRUG: Placebo
DRUG: Deutivacaftor
DRUG: VX-828

Sponsor

Vertex Pharmaceuticals Incorporated